Jill D. Martin

Array ( [id] => 3866832 [patent_doc_number] => 05837538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Patched genes and their use' [patent_app_type] => 1 [patent_app_number] => 8/540406 [patent_app_country] => US [patent_app_date] => 1995-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10077 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837538.pdf [firstpage_image] =>[orig_patent_app_number] => 540406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805849 [patent_doc_number] => 05830879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Treatment of vascular injury using vascular endothelial growth factor' [patent_app_type] => 1 [patent_app_number] => 8/538301 [patent_app_country] => US [patent_app_date] => 1995-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 9721 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830879.pdf [firstpage_image] =>[orig_patent_app_number] => 538301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854375 [patent_doc_number] => 05767337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient \"knockout\" mice' [patent_app_type] => 1 [patent_app_number] => 8/509521 [patent_app_country] => US [patent_app_date] => 1995-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5985 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767337.pdf [firstpage_image] =>[orig_patent_app_number] => 509521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181204 [patent_doc_number] => 06159680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Assay for pharmacological agents that block neurofibromin action' [patent_app_type] => 1 [patent_app_number] => 8/499419 [patent_app_country] => US [patent_app_date] => 1995-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 17640 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159680.pdf [firstpage_image] =>[orig_patent_app_number] => 499419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140307 [patent_doc_number] => 06030794 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Genetically engineered mice and cell lines containing alterations in the genes encoding retinoic acid receptor and retinoid X receptor proteins' [patent_app_type] => 1 [patent_app_number] => 8/373224 [patent_app_country] => US [patent_app_date] => 1995-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 133 [patent_no_of_words] => 40039 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030794.pdf [firstpage_image] =>[orig_patent_app_number] => 373224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044940 [patent_doc_number] => 05908777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-01 [patent_title] => 'Lipidic vector for nucleic acid delivery' [patent_app_type] => 1 [patent_app_number] => 8/494296 [patent_app_country] => US [patent_app_date] => 1995-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5289 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/908/05908777.pdf [firstpage_image] =>[orig_patent_app_number] => 494296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126025 [patent_doc_number] => 06146623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'In vitro-derived genetically altered human neutrophil precursor cells and methods for administering the same' [patent_app_type] => 1 [patent_app_number] => 8/485579 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8657 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146623.pdf [firstpage_image] =>[orig_patent_app_number] => 485579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080198 [patent_doc_number] => 06054313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'Nucleic acid and amino acid sequences for mammalian sulfonylurea receptor' [patent_app_type] => 1 [patent_app_number] => 8/488546 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 41392 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054313.pdf [firstpage_image] =>[orig_patent_app_number] => 488546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4047972 [patent_doc_number] => 05912411 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Mice transgenic for a tetracycline-inducible transcriptional activator' [patent_app_type] => 1 [patent_app_number] => 8/487472 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 41672 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912411.pdf [firstpage_image] =>[orig_patent_app_number] => 487472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4001147 [patent_doc_number] => 05888499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells' [patent_app_type] => 1 [patent_app_number] => 8/481894 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 8638 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888499.pdf [firstpage_image] =>[orig_patent_app_number] => 481894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322378 [patent_doc_number] => 06319494 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Chimeric chains for receptor-associated signal transduction pathways' [patent_app_type] => 1 [patent_app_number] => 8/479737 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21289 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319494.pdf [firstpage_image] =>[orig_patent_app_number] => 479737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007728 [patent_doc_number] => 05859310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Mice transgenic for a tetracycline-controlled transcriptional activator' [patent_app_type] => 1 [patent_app_number] => 8/481970 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 36 [patent_no_of_words] => 26930 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859310.pdf [firstpage_image] =>[orig_patent_app_number] => 481970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294230 [patent_doc_number] => 06180613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'AAV-mediated delivery of DNA to cells of the nervous system' [patent_app_type] => 1 [patent_app_number] => 8/467044 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 15349 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180613.pdf [firstpage_image] =>[orig_patent_app_number] => 467044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992870 [patent_doc_number] => 05858326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Methods of increasing amyloid deposition' [patent_app_type] => 1 [patent_app_number] => 8/471093 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5108 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858326.pdf [firstpage_image] =>[orig_patent_app_number] => 471093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3814591 [patent_doc_number] => 05770443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/471058 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9114 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770443.pdf [firstpage_image] =>[orig_patent_app_number] => 471058 [rel_patent_id] =>[rel_patent_doc_number] =>)